Heidelberg Pharma AG
HPHA.DE
Price:
$3
Market Cap:
$139.80M
Heidelberg Pharma AG, a biopharmaceutical company, focuses on oncology and antibody targeted amanitin conjugates (ATAC) in Germany, other European countries, the United States, and internationally. Its lead product candidate is HDP-101, which in the Phase I/IIa study for the treatment of relapsed or refractory multiple myeloma. It is developing HDP-102 for the treatment of non-Hodgkin lymphoma; HDP-103, an ATAC candidate to treat metastatic castration-resistant prostate cancer; HDP-104 for tumors; and HDP-XX for the treatment of solid/hematological tumors. The company is also developing MGTA-ATACs for HSCs, conditioning programs to treat blood cancers/genetic diseases; TAK-ATACs for oncology...[Read more]
Industry
Biotechnology
IPO Date
2006-11-13
Stock Exchange
XETRA
Ticker
HPHA.DE
PE Ratio
[-7.32]
ROE
[-43.79%]
Current Ratio
[6.01]
Dividend Yield
[0%]
Enterprise Value
[103.39M]
Dividend History
The ROE as of April 2025 (TTM) for Heidelberg Pharma AG (HPHA.DE) is -43.79%
According to Heidelberg Pharma AG’s latest financial reports and current stock price. The company's current ROE is -43.79%. This represents a change of 290.55% compared to the average of -11.21% of the last 4 quarters.
Heidelberg Pharma AG (HPHA.DE) Historical ROE (quarterly & annually)
How has HPHA.DE ROE performed in the past?
The mean historical ROE of Heidelberg Pharma AG over the last ten years is -93.07%. The current -43.79% ROE has changed -52.95% with respect to the historical average. Over the past ten years (40 quarters), HPHA.DE's ROE was at its highest in in the May 2021 quarter at 9.17%. The ROE was at its lowest in in the November 2021 quarter at -108.79%.
Average
-93.07%
Median
-55.14%
Minimum
-397.59%
Maximum
-29.56%
Heidelberg Pharma AG (HPHA.DE) ROE by Quarter and Year
Discovering the peaks and valleys of Heidelberg Pharma AG ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 178.69%
Maximum Annual ROE = -29.56%
Minimum Annual Increase = -92.56%
Minimum Annual ROE = -397.59%
| Year | ROE | Change |
|---|---|---|
| 2023 | -41.24% | 39.49% |
| 2022 | -29.56% | -92.56% |
| 2021 | -397.59% | 178.69% |
| 2020 | -142.66% | 129.05% |
| 2019 | -62.28% | 38.13% |
| 2018 | -45.09% | 52.18% |
| 2017 | -29.63% | -54.75% |
| 2016 | -65.49% | -5.24% |
| 2015 | -69.11% | 43.97% |
| 2014 | -48.00% | 42.38% |
Heidelberg Pharma AG (HPHA.DE) Average ROE
How has HPHA.DE ROE performed in the past?
The current ROE of Heidelberg Pharma AG (HPHA.DE) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-156.13%
5-year avg
-134.67%
10-year avg
-93.07%
Heidelberg Pharma AG (HPHA.DE) ROE vs. Peers
How is HPHA.DE’s ROE compared to its peers?
Heidelberg Pharma AG’s ROE is less than Formycon AG (12.31%), less than MorphoSys AG (742.62%), greater than Medigene AG (-58.49%), greater than Biofrontera AG (-459.54%), less than Medios AG (2.52%),
| Company | ROE | Market cap |
|---|---|---|
| 12.31% | $416.00M | |
| 742.62% | $2.53B | |
| -58.49% | $1.97M | |
| -459.54% | $20.67M | |
| 2.52% | $288.21M |
Build a custom stock screener for Heidelberg Pharma AG (HPHA.DE) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Heidelberg Pharma AG using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Heidelberg Pharma AG (HPHA.DE) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Heidelberg Pharma AG or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Heidelberg Pharma AG's ROE?
How is the ROE calculated for Heidelberg Pharma AG (HPHA.DE)?
What is the highest ROE for Heidelberg Pharma AG (HPHA.DE)?
What is the 3-year average ROE for Heidelberg Pharma AG (HPHA.DE)?
What is the 5-year average ROE for Heidelberg Pharma AG (HPHA.DE)?
How does the current ROE for Heidelberg Pharma AG (HPHA.DE) compare to its historical average?